[144/A] MetLife, Inc. SEC Filing

Rhea-AI Filing Summary

MetLife has filed a Form 144/A notice for the proposed sale of securities, detailing planned transactions of 547 shares of common stock with an aggregate market value of $42,966.85 through Barclays Capital on the NYSE, scheduled for June 20, 2025.

The securities to be sold were originally acquired in two separate purchases from Deutsche Bank:

• 272 shares acquired on September 20, 2013
• 275 shares acquired on March 21, 2014

Recent trading activity in the past 3 months includes sales by various MetLife accounts totaling 686 shares with combined gross proceeds of $55,391.75. The largest transaction was by the MetLife 401k Plan Trust-Large Cap Equity Index, selling 335 shares for $27,590.60 on March 21, 2025. The company has approximately 671.3 million shares outstanding.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144/A

144/A: Filer Information

Filer CIK
Filer CCC
Previous Accession Number Of The Filing
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144/A: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144/A: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	Barclays Capital 745 Seventh Ave New York NY 10019	547	42966.85	671297826	06/20/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144/A: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	09/20/2013	Purchase	DEUTSCHE BANK			272	09/25/2013	Cash
Common Stock	03/21/2014	Purchase	DEUTSCHE BANK			275	03/26/2014	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144/A: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
MetLife 401k Plan Trust-Large Cap Equity Index 1 Metlife Way Whippany NJ 07981	Common Stock	03/21/2025	335	27590.6
Separate Account SPI 1 Metlife Way Whippany NJ 07981	Common Stock	03/21/2025	77	6341.72
Separate Account II 1 Metlife Way Whippany NJ 07981	Common Stock	03/21/2025	47	3870.92
Separate Account 149 1 Metlife Way Whippany NJ 07981	Common Stock	03/21/2025	6	494.16
Separate Account II 1 Metlife Way Whippany NJ 07981	Common Stock	06/13/2025	221	17094.35

144/A: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

How many MET shares are being sold according to the June 2025 Form 144/A filing?

According to the Form 144/A filing, 547 shares of MetLife (MET) common stock are proposed to be sold through Barclays Capital, with an aggregate market value of $42,966.85.

When were the MET shares originally acquired that are being sold in this Form 144/A?

The shares being sold were acquired in two separate purchases: 272 shares were acquired from Deutsche Bank on September 20, 2013, and 275 shares were acquired from Deutsche Bank on March 21, 2014. Both purchases were made with cash payment.

What recent insider sales of MET stock occurred in the 3 months prior to this Form 144/A?

Several MetLife-affiliated accounts sold shares in recent months: On March 21, 2025, the MetLife 401k Plan Trust sold 335 shares ($27,590.60), Separate Account SPI sold 77 shares ($6,341.72), Separate Account II sold 47 shares ($3,870.92), and Separate Account 149 sold 6 shares ($494.16). Additionally, Separate Account II sold 221 shares ($17,094.35) on June 13, 2025.

What is the total number of MET shares outstanding as of June 2025?

According to the Form 144/A filing, MetLife (MET) had 671,297,826 shares outstanding at the time of the filing in June 2025.

What is the proposed date of sale for the MET shares in this Form 144/A?

The Form 144/A indicates that the approximate date of sale for the 547 shares is June 20, 2025, and they will be sold on the NYSE (New York Stock Exchange).